Issue Archive
|
Subscribe
|
Editorial Board
|
About
|
Contact
|
Advertise
Home
News
FDA News
Malpractice News
Features
Meetings Calendar
Urology
Bladder Cancer
Benign Prostatic Hyperplasia
Erectile Dysfunction
Kidney Cancer
Kidney Stones
Overactive Bladder
Premature Ejaculation
Prostate Cancer
Prostate Specific Antigen
Reproductive Medicine
Urinary Incontinence
Urinary Tract Infections
Nephrology
Acute Renal Failure
Anemia
Chronic Kidney Disease
Contrast Nephropathy
Cardiovascular Disease
Diabetes
Diabetic Nephropathy
Focal Segmental Glomerulosclerosis
Hemodialysis
Hypertension
Kidney Cancer
Kidney Stones
Lupus Nephritis
Peritoneal Dialysis
Secondary Hyperparathyroidism
Transplantation
Clinical Trials
Commentary
Jobs
myCME
Drug Info
MPR Drug Database
Fosrenol Package Insert
Resources
Departments:
Cleveland Clinic
World Literature Review
Legal Issues
Renal Nutrition Update
Your Money
Your Practice
RSS
|
Login
|
Register
Pediatric Urology Articles
Study: Renal Scarring More Likely in Boys
Jody A. Charnow
April 11, 2008
THE MOST significant risk factors for renal scarring in children with primary vesicoureteral reflux (VUR) are high-grade reflux, age at VUR diagnosis greater than five years, and male gender, according to a report in Nephrology (2008;13:38-42).
Study: CRP Levels May Identify High-Grade VUR
Jody A. Charnow
August 01, 2007
A fever of 38.5ยบ C or higher may predict which children have vesicoureteral reflux (VUR), and C-reactive protein (CRP) levels above 50 mg/L may identify children with high-grade VUR, a Turkish study found.
Endoscopic Injections Could Improve VUR
Jody A. Charnow
November 01, 2006
ENDOSCOPIC injection of hyaluronic acid/dextranomer (NASHA/Dx) gel can be considered as a first-line option for vesicoureteral reflux (VUR) in children, researchers say.
Bilateral Scars May Worsen Outcomes
Jody A. Charnow
October 01, 2006
CHILDREN treated for vesicoureteral reflux (VUR) may be at higher risk of diminished kidney function in middle age if they suffered bilateral renal scarring, investigators report.
« Previous
Next »
Most Popular
Most Emailed
Most Recent
Alpha Blocker Approved for BPH Treatment
New Drug Found Effective for Metastatic RCC
Managing Post-Transplant Infections
Taking on the Issue of Transplant Tourism
Age Alone Should Not Deter ADT Use
Elderly May Need Different Bladder Ca Treatment
More Frequent Dialysis Has Benefit
Discrepancies Common in Surgical Sponge Counts
New Drug Found Effective for Metastatic RCC
Post-Tranplant UTI Pathogens Shift Over Time
New Drug Found Effective for Metastatic RCC
Stents May Shorten Dialysis Duration
Personalized RCC Treatment May Be Superior
Catheter-Associated UTIs Raise Death Risk
Managing Post-Transplant Infections
Age Alone Should Not Deter ADT Use
Oral Insulin Spray Showing Promise
Post-Tranplant UTI Pathogens Shift Over Time
Anti-Malaria Drug May Prevent SLE Renal Damage
Statins Cut Infection Risk in Transplant Patients
Meetings Calendar
Program Benefits Poor PCa Patients
Elderly May Need Different Bladder Ca Treatment
Hypomagnesemia Is Often Neglected
Hypomagnesemia Is Often Neglected
Aliskiren Offers Better BP Control
Managing Post-Transplant Infections
Taking on the Issue of Transplant Tourism
Post-Tranplant UTI Pathogens Shift Over Time
Age Alone Should Not Deter ADT Use
Popular Tags
Acute Renal Failure
Anemia
Bladder Cancer
BPH
Cardiovascular disease
CKD
Diabetes
Diabetic Nephropathy
Epidemiology
Erectile Dysfunction
Hemodialysis
Hypertension
Kidney Cancer
Kidney Stones
Lupus nephritis
Peritoneal Dialysis
Prostate Cancer
PSA
Reproductive medicine
Transplantation
Urinary Incontinence
UTI
Sponsored Links